Health

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…

3 weeks ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

3 weeks ago

Smartee and Straumann Announce Strategic Partnerships to Accelerate Innovation in Orthodontics

SHANGHAI, Oct. 29, 2025 /PRNewswire/ -- Smartee Denti-Technology and Straumann Group announce a strategic partnership. This partnership encompasses joint development…

3 weeks ago

SI GROUP OPENS NEW INNOVATION CENTER

State-of-the-art facility expands company's global research and development capabilities THE WOODLANDS, Texas, Oct. 28, 2025 /PRNewswire/ -- SI Group, a…

3 weeks ago

Edesa Biotech Announces Upcoming Conference Schedule

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…

3 weeks ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

3 weeks ago

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies,…

3 weeks ago

Star Health Reports 21% YoY Profit Growth to 518 Cr; COR Improves by 170 bps in H1FY26 under IFRS

24% growth in fresh retail premiums Expense ratio improves to 29.7% from 31.1% (IFRS) CHENNAI, India, Oct. 29, 2025 /PRNewswire/…

3 weeks ago

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol…

4 weeks ago

Bright Minds Biosciences toPresent at Upcoming Conferences

October 30, 2025 18:30 ET  | Source: Bright Minds Biosciences NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds…

4 weeks ago